Growth Metrics

908 Devices (MASS) Liabilities from Discontinued Operations (2024)

908 Devices (MASS) reported Liabilities from Discontinued Operations of 4696000.0 for Q4 2024.

908 Devices (MASS) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 4696000.0 in Q4 2024.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 4696000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 4696000.0 (changed N/A YoY) and the FY2024 annual result came in at 4696000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations steadied at 4696000.0 in Q4 2024 per MASS's latest filing.
  • Across five years, Liabilities from Discontinued Operations topped out at 4696000.0 in Q4 2024 and bottomed at 4696000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 908 Devices 314.43 Mn 202.69 Mn 6.88 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 4.70 Mn
Dec 31, 2024 4.70 Mn